Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Diana Jaber"'
Autor:
Mohamed Ghaly, Diana Jaber, Mario Matthaei, Claus Cursiefen, Alexander Händel, Juliane Köberlein-Neu, Robert Hörster, Sebastian Siebelmann
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Analysis of internet search queries (ISQ) could be useful to study public interest and medical need for corneal, cataract, and refractive surgery. To date, there are preliminary data on seasonal trends in ophthalmic conditions, but only few
Externí odkaz:
https://doaj.org/article/612c7e24ab1d4843bf28e87a0c5de1f9
Publikováno v:
The Journal of Clinical Ethics. 33:240-244
A patient with a history of bipolar II disorder and end-stage renal disease who required hemodialysis for five years abruptly wished to withdraw from dialysis on day seven of her hospital admission for a urinary tract infection. She had never discuss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20f113d06cfd4a01178fbe2ccc504735
https://doi.org/10.1086/jce2022333240
https://doi.org/10.1086/jce2022333240
Autor:
Kate Zarzuela, Linh Nguyen, Fabian Vargas, Mahad Musse, Monika M. Safford, Parag Goyal, Diana Jaber, Emily B. Levitan, Mathew S. Maurer, Mark S. Lachs, Min Ji Kwak, Joanna Bryan Ringel
Publikováno v:
J Card Fail
Objectives To better understand patterns of potentially inappropriate medications (PIMs) from the Beers criteria among older adults hospitalized with heart failure (HF). Design/Setting Observational study of hospitalizations derived from the geograph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4253b30d564bb97286b2c3a2f215647
https://doi.org/10.1016/j.cardfail.2021.11.014
https://doi.org/10.1016/j.cardfail.2021.11.014
Publikováno v:
International Journal of Geriatric Psychiatry. 37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2ffa42fed1c149b1a7269896b0883c
https://doi.org/10.1002/gps.5768
https://doi.org/10.1002/gps.5768
Autor:
Mark S. Lachs, Kate Zarzuela, Elissa Kozlov, Diana Jaber, Tatiana Requijo, Pedram Navid, Marcos Lu Wang, Parag Goyal, Mahad Musse, Linh Nguyen, Sarah N. Hilmer, Ruth M. Masterson Creber
Publikováno v:
J Am Geriatr Soc
BACKGROUND/OBJECTIVES Attitudes toward deprescribing could vary among subpopulations. We sought to understand patient attitudes toward deprescribing among patients with heart failure with preserved ejection fraction (HFpEF). DESIGN Retrospective coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2599bef1991889330ab078391b28508b
https://europepmc.org/articles/PMC9198814/
https://europepmc.org/articles/PMC9198814/
Autor:
Richard T. Silver, Ghaith Abu-Zeinah, Claudia Sosner, Ellen K. Ritchie, Diana Jaber, Niamh Savage, Gabriela Hoberman, Tatiana Cruz, Spencer Krichevsky, Joseph M. Scandura
Publikováno v:
Leukemia
Interferon-alpha (rIFNα) is the only disease-modifying treatment for polycythemia vera (PV), but whether or not it prolongs survival is unknown. This large single center retrospective study of 470 PV patients compares the myelofibrosis-free survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de7da6d24ac657878289f40dbd4e733
https://europepmc.org/articles/PMC8410882/
https://europepmc.org/articles/PMC8410882/
Autor:
Ghaith Abu Zeinah, Spencer Krichevsky, Diana Jaber, Niamh Savage, Claudia Sosner, Gabriela Hoberman, Ellen K. Ritchie, Andrew I. Schafer, Joseph Scandura, Richard T. Silver
Publikováno v:
Blood. 134:2942-2942
Introduction: The progression of polycythemia vera (PV) to myelofibrosis (MF) is associated with significant morbidity and mortality. Interferon alfa (rIFNa), a disease-modifying agent, has potential to delay or prevent post-PV MF and improve overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6579e2cf825f8cebfd7824254d96ed1
https://doi.org/10.1182/blood-2019-130265
https://doi.org/10.1182/blood-2019-130265
Autor:
Niamh Savage, Diana Jaber, Gabriela Hoberman, Richard T. Silver, Andrew I. Schafer, Spencer Krichevsky, Joseph M. Scandura, Ellen K. Ritchie, Claudia Sosner, Ghaith Abu Zeinah
Publikováno v:
Blood. 134:1664-1664
Introduction: Polycythemia vera (PV) is characterized by an increased red cell mass resulting in whole blood hyperviscosity, a strong predictor for thrombosis which remains a significant cause of morbidity and mortality1. Leukocytosis, thrombocytosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfbce80e62180c5ee44fc8f00161ccf6
https://doi.org/10.1182/blood-2019-131605
https://doi.org/10.1182/blood-2019-131605